Analysis of anticancer drugs in sewage water by selective SPE and UPLC-ESI-MS-MS

Journal of Chromatographic Science

Volumn 48, Issue 10, 2010, Pages 781-789

  Yin, Jie ^a,b   Yang, Yi ^b   Li, Keji ^a   Zhang, Jing ^b   Shao, Bing ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149292845     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.10.781     Document Type: Article

References (27)

1. WHO, Fact Sheet No. 310, 2008, http://www.who.int/mediacentre/factsheets/ fs310/en/index.html
2. Ministry of Health of the People's Republic of China, 2007 China Health Statistical Yearbook, 2008, http://61.49.18.65/publicfiles/business/htmlfiles/ zwgkzt/ptjnj/year2008/10.htm. Accessed 21.05.09
3. http://www.chinapharm.com.cn/html/scfx/12593420050228.html. Accessed 21.05.09 [in chinese]
4. K. Falck, P. Grohn, M. Sorsa, H. Vainio, E. Heinonen, and L.R. Holsti. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1(8128): 1250-1251 (1979).
5. M.A. Jackson, H.F. Stack, and M.D. Waters. Genetic activity profiles of anticancer drugs. Mutat. Res. 355(1-2): 171-208 (1996).
6. M.A. Santos and M. Pacheco. Mutagenicity of cyclophosphamide and kraft mill effluent and sediment on the eel Anguilla anguilla. Sci. Total. Environ. 171:127-130 (1995).
7. M.P. DeMeo, S. Merono, A.D. DeBaille, A. Botta, M. Laget, H. Guiraud, and G. Dumenil. Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials. Int. Arch .Occup. Environ. Health 66(6): 363-368 (1995).
8. Z. Rong and H. Yin. A method for genotoxicity detection using random amplified polymorphism DNA with Danio rerio. Eco- toxicol. Environ. Saf. 58(1): 96-103 (2004).
9. IARC, IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, 2008, http://monographs.iarc.fr/ENG/Classification/index.php. Accessed 21.05.09
10. C.G. Daughton and T.A. Ternes. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health. Perspect. 107 Suppl 6: 907-938 (1999).
11. U.S. EPA, EPA PPCP Research Areas, 2008, http://www.epa.gov/ppcp/work2. html#sources.
12. R. Turci, C. Sottani, G. Spagnoli, and C. Minoia. Biological and environmental monitoring of hospital personnel exposed to anti- neoplastic agents: a review of analytical methods. J. Chromatogr. B 789(2): 169-209 (2003).
13. T. Steger-Hartmann, K. Kummerer, and J. Schecker. Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by two step solid-phase extraction and gas chro- matography-mass spectrometry. J. Chromatogr. A 726(1-2): 179-184 (1996).
14. S.N. Mahnik, K. Lenz, N. Weissenbacher, R.M. Mader, and M. Fuerhacker. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 66(1): 30-37 (2007).
15. K. Kümmerer, T. Steger-Hartmann, and M. Meyer. Biodegrad- ability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Res. 31(11): 2705-2710 (1997).
16. T. Steger-Hartmann, K. Kummerer, and A. Hartmann. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol. Environ. Saf. 36(2): 174-179 (1997).
17. S. Castiglioni, R. Bagnati, D. Calamari, R. Fanelli, and E. Zuccato. A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spec- trometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters. J. Chromatogr. A 1092(2): 206-215 (2005).
18. I.J. Buerge, H.R. Buser, T. Poiger, and M.D. Muller. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environ. Sci. Technol. 40(23): 7242-7250 (2006).
19. Thekla Kiffmeyer and Martin Jursch. Trace enrichment, chro- matographic separation and biodegradation of cytostatic compounds in surface water. Fresenius. J. Anal. Chem. 361: 185-191 (1998).
20. S.N. Mahnik, B. Rizovski, M. Fuerhacker, and R.M. Mader. Development of an analytical method for the determination of anthra- cyclines in hospital effluents. Chemosphere 65(8): 1419-1425 (2006).
21. S. Castiglioni, R. Bagnati, and R. Fanelli, Removal of pharma- ceuticals in sewage treatment plants in italy. Environ. Sci. Technol. 40: 357-363 (2006).
22. F. Sacher, F.T. Lange, H.J. Brauch, and I. Blankenhorn. Pharma- ceuticals in groundwaters analytical methods and results of a monitoring program in Baden-Wrttemberg, Germany. J. Chro- matogr. A 938(1-2): 199-210 (2001).
23. A. Tanabe and K. Kawata. Determination of triazine pesticides and related compounds in environmental water by liquid chro- matography-mass spectrometry. Anal. Sci. 20(1): 227-230 (2004).
24. I. Tolosa, B. Douy, and F.P. Carvalho. Comparison of the performance of graphitized carbon black and poly(styrene-divinylben- zene) cartridges for the determination of pesticides and industrial phosphates in environmental waters. J. Chromatogr. A 864(1): 121-136 (1999).
25. A. Lagana, A. Bacaloni, G. Fago, and A. Marino. Trace analysis of estrogenic chemicals in sewage effluent using liquid chroma- tography combined with tandem mass spectrometry. Rapid. Commun. Mass. Spectrom. 14(6): 401-407 (2000).
26. I. Taverniers, M.D. Loose, and E.V. Bockstaele. Trends in quality in the analytical laboratory. II. Analytical method validation and quality assurance. Trends Anal. Chem. 23(8): 535-552 (2004).
27. FDA, Preparation and LC/MS/MS analysis of honey for fluoro- quinolone residues-attachment E: quantification using standard additions. 2006, http://www.fda.gov/Food/ScienceResearch/LaboratoryMethods/ DrugChemicalResiduesMethodology/ ucm071495.htm. Accessed 06.06.09